Overdoses and ingestions of second-generation antipsychotics in children and adolescents

Journal of Child and Adolescent Psychopharmacology

Volumn 15, Issue 6, 2005, Pages 970-985

  Antia, Smita X ^a   Sholevar, Ellen H ^a   Baron, David A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACTIVATED CARBON; ADRENALIN; ARIPIPRAZOLE; ATROPINE; CLOZAPINE; DESMOPRESSIN; DIAZEPAM; DIPHENHYDRAMINE; INFUSION FLUID; IPECAC; MAGNESIUM CITRATE; METOCLOPRAMIDE; NALOXONE; NEUROLEPTIC AGENT; NORADRENALIN; NORCLOZAPINE; OLANZAPINE; ONDANSETRON; QUETIAPINE; RISPERIDONE; SEDATIVE AGENT; SORBITOL; TRIAMCINOLONE; ZIPRASIDONE;

AGITATION; ARTIFICIAL VENTILATION; CLINICAL FEATURE; DROWSINESS; DRUG BLOOD LEVEL; DRUG FATALITY; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; HUMAN; INTUBATION; IRRITABILITY; LETHARGY; MEDLINE; PRESCRIPTION; REVIEW; STOMACH LAVAGE; TACHYCARDIA;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CAUSE OF DEATH; CHILD; CLOZAPINE; FEMALE; HUMANS; MALE; NEUROLOGIC EXAMINATION; OVERDOSE; RISPERIDONE; SURVIVAL RATE;

EID: 29944436262     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2005.15.970     Document Type: Review

References (55)

1. Acri A, Henretig F: Effects of risperidone in overdose. Am J Emerg Med 16(5):498-501, 1998.
2. Ashcroft D, Frischer M, Lockett J, Chapman S: Variations in prescribing second-generation antipsychotic drugs in primary care: cross-sectional study. Pharmacoepid Drug Safety 11(4):285-289, 2002.
3. Biswas AK, Zabrocki LA, Mayes KL, Morris-Kukoski CL: Cardiotoxicity associated with intentional ziprasidone and bupropion overdose. J Toxicol Clin Toxicol 41(2):101-104, 2003.
4. Bond RG, Thompson JD: Olanzapine pediatric overdose. Ann Emerg Med 34(2):292-293, 1999.
5. Bonin MM, Burkhart KK: Olanzapine overdose in a one-year-old male. Pediatr Emerg Care 15(4):266-267, 1999.
6. Borzutzky A, Rumie H, Paris E: Accidental clozapine ingestion in a ten-year-old child. Vet Hum Toxicol 45(6):309-310, 2003.
7. Bryant SM, Zilberstein J, Cumpston KL, Magdziarz DD, Costerisan D: A case series of ziprasidone overdose. Vet Hum Toxicol 45(2):81-82, 2003.
8. Catalano G, Cooper DS, Catalano MC, Butera AS: Olanzapine overdose in an eighteen-month-old child. J Child Adolesc Psychopharmacol 9(4):267-271, 1999.
9. Catalano G, Catalano M, Nunez C, Walker S: Second-generation antipsychotic overdose in the pediatric population. J Child Adolesc Psychopharmacol 11(4):425-434, 2001.
10. Catalano G, Catalano MC, Agustines RE, Dolan EM, Paperwalla KN: Pediatric quetiapine overdose: A case report and literature review. J Child Adolesc Psychopharmacol 12(4):355-361, 2002.
11. Chambers RA, Caracansi A, Weiss G: Olanzapine overdose cause of acute EPS. Am J Psychiatry 155(11):1630-1631, 1998.
12. Cheslik T, Erramouspe J: Extrapyramidal symptoms following accidental ingestion of risperidone in a child. Ann Pharmacother 30:360-363, 1996.
13. Cheng-Shannon J, McGough J, Pataki C, McCracken, J: Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol 14(3):372-394, 2004.
14. Daniel DG, Copeland LF, Tamminga C: Ziprasidone. In: Textbook of Psychopharmacology, Third Edition. Schatzberg A, Nemeroff C, eds. Washington (DC), American Psychiatric Publishing, 2004, pp 507-518.
15. Dougherty TJ, Greene TF, Farrell SE, Roberts JR: Adult and pediatric olanzapine (Zyprexa) overdose. Clin Toxicol 35(5):550, 1997.
16. Etienne L, Wittebole X, Liolios A, Hantson P: Polyuria after olanzapine overdose. Am J Psychiatry 161(6):1130, 2004.
17. Findling RL, Schulz SC, Reed MD, Blumer JL: The antipsyhotics. A pediatric perspective. Pediatr Clin North Am 45(5):1205-1232, 1998.
18. Goetz CM, Love RC, Schuster P: Overdose of clozapine in a child. Vet Hum Toxicol 35(4):338, 1993.
19. Goff DC: Risperidone. In: Textbook of Psychopharmacology, Third Edition. Schatzberg A, Nemeroff C, eds. Washington (DC), American Psychiatric Publishing, 2004, pp 495-506.
20. Hadley CM, Walson PD: Pediatric clozapine ingestion. Vet Hum Toxicol 35(4):338, 1993.
21. Hermann R, Yang D, Ettner S, Marcus S, Yoon C, Abraham M: Prescription of antipsychotic drugs by office-based physicians in the United States, 1989-1997. Psychiatr Serv 53:425-430, 2002.
22. Himstreet J, Daya M: Hypotension and orthostasis following a risperidone overdose. Ann Pharmacother 32:267, 1998.
23. Jacobs ES, Dickstein DP, Liebelt EL: Novel psychotropic medications in children: New toxicities to master. Peditr Emerg Care 17(3):226-230, 2001.
24. Juhl GA, Benitez JG, McFarland S: Acute quetiapine overdose in an eleven-year-old girl. Vet Hum Toxicol 44(3):163-164, 2002.
25. Keller T, Miki A, Binda S, Dirnhofer R: Fatal overdose of clozapine. Forens Sci Int 86:119-125, 1997.
26. Kochhar S, Nwokike J, Jankowitz B, Sholevar EH, Abed T, Baron DA: Olanzapine overdose: A pediatric case report. J Child Adolesc Psychopharmacol 12(4):351-353, 2002.
27. Kurth J, Maguire G: Pediatric case report of quetiapine overdose and QTc prolongation. Ann Clin Psychiatry 16:229-231, 2004.
28. Kuspis D, Dean B, Krenzelok EP: Risperidone overdose assessment. J Toxicol Clin Toxicol 33:552, 1995.
29. Leslie D, Rosenheck, R: From conventional to second-generation antipsychotics and back: Dynamic processes in the diffusion of new medications. Am J Psychiatry 159(9):1534-1540, 2002.
30. Lackey G, Alsop J, Albertson T: A one-year review of pediatric ziprasidone ingestions. J Toxicol Clin Toxicol 40:624, 2002.
31. Liebelt E, DeAngelis C: Evolving trends and treatment advances in pediatric poisoning. J Am Med Assn 282(12):1113-1115, 1999.
32. Lieberman J: Quetiapine. In: Textbook of Psychopharmacology. Schatzberg A, Nemeroff C, eds. Washington (DC), American Psychiatric Publishing, 2004a, pp 473-486.
33. Lieberman J: Aripiprazole. In: Textbook of Psychopharmacology. Schatzberg A, Nemeroff C, eds. Washington (DC), American Psychiatric Publishing, 2004b, pp 487-494.
34. Litovitz TL, Klein-Schwartz W, Dyer KS, Shannon M, Lee S, Powers M: 1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 16(5):443-497, 1998.
35. Litovitz TL, Klein-Schwartz W, White S, Cobaugh DJ, Youniss J, Drab A, Benson BE: 1999 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 18(5):517-574, 2000.
36. Litovitz TL, Klein-Schwartz W, White S, Cobaugh DJ, Youniss J, Omslaer J, Drab A, Benson BE: 2000 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 19(5):337-395, 2001.
37. Litovitz TL, Klein-Schwartz W, Rodgers GC, Jr, Cobaugh DJ, Youniss J, Omslaer JC, May ME, Woolf AD, Benson BE: 2001 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 20(5):391-452, 2002.
38. Litovitz T, Manoguerra A: Comparison of pediatric poisoning hazards: An analysis of 3.8 million exposure incidents. Pediatrics 89(6):999-1006, 2002.
39. Lofton AL, Klein-Schwartz W: Atypical experience: A case series of pediatric aripiprazole exposures. Clin Toxicol 43(3):151-153, 2005.
40. Mady SP, Wax P: Clozapine intoxication in a young child. Vet Hum Toxicol 35(4):338, 1993.
41. Mady S, Wax P, Wang D, Goetz C, Hadley C, Love R: Pediatric clozapine intoxication. Am J Emerg Med 14:462-463, 1996.
42. Malone RP, Sheikh R, Zito JM: Psychopharmacology: Novel antipsychotic medications in the treatment of children and adolescents. Psych Serv 50:171-174, 1999.
43. Marder S, Wirshing D: Clozapine. In: Textbook of Psychopharmacology. Schatzberg A, Nemeroff C, eds. Washington (DC), American Psychiatric Publishing, 2004, pp 443-456.
44. Powell G, Nelson L, Huffman R: Overdose of olanzapine (Zyprexa), a new antipsychotic agent. J Toxicol Clin Toxicol 35:550, 1997.
45. Schonberger RB, Douglas L, Baum CR: Severe extrapyramidal symptoms in a 3-year-old boy after accidental ingestion of the new antipsychotic drug aripiprazole. Pediatrics 114(6):1743, 2004.
46. Schulz SC, Olson S, Kotlyar M: Olanzapine. In: Textbook of Psychopharmacology. Schatzberg A, Nemeroff C, eds. Washington (DC), American Psychiatric Publishing, 2004, pp 457-472.
47. Seifert SA, Schwartz MD, Thomas JD: Aripiprazole overdose in a child. Clin Toxicol 43(3):193-195, 2005.
48. Teasdale G, Jennet B: Assessment of coma and impaired consciousness: A practical scale. Lancet 2:81-84, 1974.
49. Watson WA, Litovitz TL, Rodgers GC, Jr, Klein-Schwartz W, Youniss J, Rose SR, Borys D, May ME: 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 21(5):353-421, 2003.
50. Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, Youniss J, Reid N, Rouse WG, Rembert RS, Borys D: 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 22(5):335-404, 2004.
51. Winans E: Aripiprazole formulary review. Am J Health Syst Pharm 60(23):2437-2445, 2003.
52. Wong I, Murray M, Camilleri-Novak D, Stephens P: Increased prescribing trends of paediatric psychotropic medications. Arch Dis Child 89(12):1131-1132, 2004.
53. Yip L, Dart R, Graham K: Olanzapine toxicity in a toddler. Pediatrics 102(6):1494, 1998.
54. Zito JM, Safer DJ, dosReis S, Gardner JF, Magder L, Soeken K, Boles M, Lynch F, Riddle MA: Psychotropic practice patterns for youth: A 10-year perspective. Arch Peds Adolesc Med 157(1):17-25, 2003.
55. Zuvekas SH. Trends in mental health services use and spending, 1987-1996. Health Aff 20:214-224, 2001.